| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. (AXSM) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. AXSM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 58.4K | $14.11M | -572 | |
| Dir | 30.4K | $7.34M | -18,180 | |
| CEO | 24.1K | $5.82M | - | |
| Other | 23.7K | $5.73M | - | |
| Dir | 11.4K | $2.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | Murdock Hunter R. | General Counsel | Sale+OE | 22,500 | $101.19 | $2,276,850.00 | -100% | +10.9% | +143.5% | |
| Jun 9, 2025 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 25,000 | $110.44 | $2,761,000.00 | -81.2% | +17.7% | +123.6% | |
| May 28, 2025 | Coleman Mark | Director | Sell | 7,500 | $104.45 | $783,375.00 | -7.2% | +17.6% | +126.1% | |
| May 28, 2025 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 40,673 | $104.07 | $4,232,636.18 | -77.9% | +17.6% | +126.1% | |
| May 20, 2025 | Coleman Mark | Director | Sell | 3,000 | $107.49 | $322,473.00 | -5.3% | +2.6% | +112.8% | |
| Feb 14, 2025 | Pizzie Nick50 | Chief Financial Officer | Sale+OE | 15,000 | $130.10 | $1,951,530.00 | -15.1% | -18.2% | +38.2% | |
| Sep 11, 2024 | Saad Mark E50 | Director | Sale+OE | 11,016 | $91.31 | $1,005,870.96 | -52.4% | +8.6% | +35.1% | |
| Aug 9, 2024 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 47,739 | $84.26 | $4,022,488.14 | -89.2% | +9.2% | +26.1% | |
| May 29, 2024 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 7,910 | $74.31 | $587,813.46 | -57.8% | +18.2% | +39.1% | |
| May 29, 2024 | Coleman Mark | Director | Sell | 10,497 | $75.17 | $789,107.29 | -23.4% | +18.2% | +39.1% |